Article · 3 May 2019
Conference abstract
Fast dissolving drug delivery systems
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Fast-dissolving formulations represent excellent opportunities for life cycle management to the pharmaceutical companies. Fast dissolving technologies have many advantages like ease of swallowing, administration without water, quick onset of action for improving both patient convenience and compliance as benefits for the patient; extended life cycle, product differentiation, patent protection as benefits for pharmaceutical companies. But there are some challenges for formulation development studies like taste -masking, disintegration time, moisture sensitivity, friability, packaging and intellectual property issues, especially for the generic companies. The technologies are under patent protection like Zydis??®, Flashtab??®, OraSolv??® and DuraSolvâ??¢, WOWTAB??®. One of the major issues is a taste-masking problem which may be overcome with using cyclodextrins, polymer coating, flavouring & sweetening agent, microencapsulation techniques. There are some modified excipients for providing both taste-masking and productability properties in the formulation like Ludiflash??®, Pharmaburst??®. From the analytical development point of view, there are a number of different methods from conventional dosage forms which are determined in the pharmacopoeias. And for comparison and assessment of taste masking, electronic tongue may be a good opportunity which was developed by Alpha M.O.S. In the sense of generic companies, developing a fast dissolving tablets version of an existing immediate-release product means that the two formulations must be bioequivalent and this can be challenging for in-vivo studies especially if the method of taste masking retards the dissolution rate of the active ingredient after disintegration. What about the future of fast dissolving technologies? Orally disintegrating extended release (ODT-ER) dosage forms are providing all of the benefits of these two drug delivery technologies in a single pharmaceutical product. And oral rapid films also may be a good alternative, especially for the OTC market.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 15 Oct 2018
Fast dissolving drug delivery systems
Conference abstract · 20 Sep 2018
FAST DISSOLVING DRUG DELIVERY SYSTEMS
Conference abstract · 26 Jul 2018
Fast dissolving drug delivery systems
Conference abstract · 2018
Fast dissolving drug delivery systems
More from this journal
The newest in Pharmaceutica Analytica Acta.
Article · 16 Sep 2026
The Fc Domains in the Monoclonal Antibody and Fusion Protein Significantly Boost the Biocomposite Suspension's Power to Combat Harmful Microorganisms, Enhance Drug Delivery, and Improve Protein Stability
Article · 26 Jun 2026
Green Pathways in Drug Quality Assessment: The Growing Role of Sustainable Pharmaceutical Analytics
Article · 26 Jun 2026
Advanced Single-Cell Signal Analysis: The Role of Ghost Cytometry in Cell Therapy Characterization
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Gulay Yelken Demirel”

